John F. Miller

President at Lotus Tissue Repair, Inc.

Health Technology

Profile

John F.
Miller is currently the President, Treasurer, Director, and Vice President at Lotus Tissue Repair, Inc. He previously held positions as the President, Treasurer, and Director at Shire Human Genetic Therapies, Inc., and as the President and Treasurer at Baxalta, Inc.

John F. Miller active positions

Companies	Position	Start
Lotus Tissue Repair, Inc. Lotus Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA.	President	-

All active positions of John F. Miller

Former positions of John F. Miller

Companies	Position	End
Shire Human Genetic Therapies, Inc. Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.	President	-
BAXALTA INC	President	-

See the detail of John F. Miller's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John F. Miller's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Baxalta, Inc. Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL.	Health Technology
Shire Human Genetic Therapies, Inc. Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.	Health Technology
Lotus Tissue Repair, Inc. Lotus Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA.	Health Technology

See company connections

Stock Market
Insiders
John F. Miller